1. Tau pretreatment significantly improved cerebral infarction volume in rats with CI2. Tau pretreatment inhibited the decrease of SOD activity after ischemia for 6 h3. Tau pretreatment inhibited ICAM-1 expression in CI rats. The gene discussed is MAPT; the disease is brain infarction.